Narivent is indicated for the:
• reduction of nasal obstruction in patients affected by nasal turbinate hypertrophy and by specific (allergic rhinitis) or non-specific vasomotor rhinitis;
• treatment of oedema associated with acute and chronic rhinosinusal and adenoid inflammatory conditions;
• treatment and prevention of post-surgical relapse of nasal polyps;
• pre- and post-surgical treatment of nasal and rhinosinusal pathologies.